Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
- Resource Type
- Article
- Authors
- Tam, Constantine S. ; Trotman, Judith; Opat, Stephen; Burger, Jan A.; Cull, Gavin; Gottlieb, David; Harrup, Rosemary; Johnston, Patrick B.; Marlton, Paula; Munoz, Javier; Seymour, John F.; Simpson, David; Tedeschi, Alessandra; Elstrom, Rebecca; Yu, Yiling; Tang, Zhiyu; Han, Lynn; Huang, Jane; Novotny, William; Wang, Lai; Roberts, Andrew W.
- Source
- In Blood 12 September 2019 134(11):851-859
- Subject
- Language
- ISSN
- 0006-4971